CHICAGO--(BUSINESS WIRE)--Exelon Corporation (Nasdaq: EXC) announced the pricing of its offering of $900 million aggregate principal amount of its 3.25% convertible senior notes due 2029 in a private ...
SAN DIEGO, Nov. 5, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), today announced that it intends to offer, subject to market conditions and other ...
CleanSpark recently raised $1.15 billion via zero-interest convertible notes to fund an HPC/AI pivot and executed a significant share buyback. CLSK's net dilution from the convertible offering is ...
WALTHAM, Mass. and BOULDER, Colo., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. ("Cogent”) (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile